Compare DexCom, Inc. (DXCM) vs Unity Software Inc (U) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Unity Software Inc — how do they compare? DexCom, Inc. trades at $77.87 (market cap $28.06B), while Unity Software Inc trades at $30.6 (market cap $13.65B). The key difference: DexCom, Inc. is far larger — about 2.1× Unity Software Inc's market cap, and DexCom, Inc. is trading nearer its 52-week high, Unity Software Inc nearer its low. Which is the better fit depends on your goals.
| DXCM | U | |
|---|---|---|
Market Cap | $28.06B | $13.65B |
Sector | Health | Technology |
52-Week High | $89.53 | $49.47 |
52-Week Low | $54.84 | $17.13 |
Enterprise Value | $27.03B | $13.75B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DXCM trades at $77.31, up 4.3% on the day, with a bullish technical outlook as it approaches resistance near $78. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $0.56 surpassing expectations of $0.47. Revenue growth accelerated to $4.66 billion in 2025, while net income margin expanded to 17.93%. Recent regulatory approvals, including Health Canada authorization for the G7 15-day CGM, support continued international expansion.
The stock offers growth potential with analyst consensus price target of $84.33, though high valuation multiples (P/E 31.21) and competition in the CGM market present risks. Expansion into non-insulin Type 2 diabetes and pediatric markets could drive future revenue, but commercial uptake remains unproven. Institutional sentiment remains strongly bullish with 80% buy ratings.
Unity Software (U) trades at $30.49, down 3.97% on the day, amid mixed technical signals with a bullish moving average trend but overbought RSI readings. The company reported Q1 2026 EPS of -$0.80, missing expectations, yet maintains strong gross margins of 62.79% and positive operating cash flow of $423M in 2025. Recent news highlights strategic shifts toward AI and advertising technology, with analyst consensus leaning bullish.
The stock offers potential upside to the $36.50 consensus price target, supported by improving revenue trends and cost controls, but faces risks from persistent net losses, high debt, and competitive pressures in the gaming and software sectors. Investor sentiment is cautiously optimistic, balancing growth initiatives against profitability challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Unity Software Inc
Unity Software Inc provides a software platform for creating and operating interactive, real-time 3D content. The platform can be used to create, run and monetize interactive, real-time 2D and 3D content for mobile phones, tablets, PCs, consoles, and augmented and virtual reality devices. The business is spread across the United States, Greater China, EMEA, APAC and Other Americas, of which key revenue is derived from the EMEA region. The products are used in the gaming industry, architecture and construction sector, animation industry, and designing sector.
Read more on U →
